ASCO: Molecular Diagnostics Allow Further Understanding of Medulloblastoma
May 29, 2014
As part of our coverage of the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, we discuss how molecular diagnosis in medulloblastoma affects clinical decision-making.
